Southern New England Heart Ball channels fundraising into cardiovascular prevention and care
Southern New England’s annual Heart Ball turned a gala evening into a direct investment in cardiovascular health, drawing more than 300 community leaders, supporters and advocates to Providence on October 2. The event centered on a simple but consequential premise: better outcomes for heart disease and stroke depend on research, public education, access to care and policy work moving in the same direction.
The setting was celebratory, but the clinical stakes were unmistakable. Cardiovascular disease remains the nation’s No. 1 killer, and the funds raised through the 2026 Southern New England Heart Ball are intended to support the American Heart Association’s work on exactly the forces that shape risk at the bedside and in the community — prevention, treatment, and the conditions that determine whether patients can actually reach care in time.
Chair Joseph Mazza, M.D., framed the evening around the progress already made and the gap that still remains. Since the American Heart Association’s founding in 1924, deaths from cardiovascular diseases have been cut in half. Yet the warning embedded in the event was hard to miss: the Association predicts that more than 6 in 10 people in the United States are likely to have some type of cardiovascular disease by 2050.
That projection is not a distant abstraction. It reflects the cumulative effect of aging populations, persistent risk factors and uneven access to prevention and treatment. As blood pressure, lipid disorders, diabetes, obesity and tobacco exposure continue to cluster across communities, the clinical burden rises long before a patient reaches a catheterization lab or stroke unit.
The Heart Ball served as the culmination of the year-round Heart of Southern New England campaign, which aims to improve and save lives from heart disease and stroke. Research discovery, advocacy, access to quality health care and practical health knowledge formed the pillars of the campaign, and the event tied those goals together in a public setting where philanthropy could be linked to tangible health consequences.
One sentence captured the evening’s central message: lifesaving cardiovascular work depends on sustained community support.
Michelle Clark, executive director of American Heart Association – Southern New England, thanked guests, sponsors and volunteers for helping extend that work through heart and brain health education, research and advocacy. In clinical terms, those are not separate lanes. Education affects symptom recognition and adherence. Advocacy influences insurance coverage, hospital access and the reach of preventive services. Research shifts standards of care by refining how clinicians prevent infarction, stroke and heart failure.
The event also put a human face on the disease burden. Survivors of heart disease, stroke and other cardiovascular challenges shared stories that reflected courage, resilience and hope. Those personal accounts matter because cardiovascular illness rarely presents as a single isolated event; it changes family routines, employment, mobility and long-term independence. Hearing from survivors also reminds clinicians and the public alike that the burden of disease is measured not only in mortality statistics, but in the months and years of recovery that follow acute events.
The region also paused to honor one of its own. The Yvonne Heredia Lifetime Achievement Award was presented to Rev. Albert Whitaker, M.A., M.P.H., D.Min., recognizing decades of leadership, service and dedication to improving the health and well-being of communities throughout Southern New England. In public health terms, that kind of recognition signals the value of trusted local leadership in reaching populations that may otherwise remain outside the orbit of conventional health messaging.
A second sentence, just as direct, captured the clinical logic behind the celebration: community trust changes whether prevention reaches the people who need it most.
Hosted by WPRI 12’s Kait Walsh, the evening also included a live auction, with one attendee taking home a guitar signed by Taylor Swift. The detail may have added a lighter note to the program, but the larger purpose stayed fixed on cardiovascular prevention and support for the American Heart Association’s mission. Fundraising events like this are often judged by atmosphere, yet their deeper significance lies in what they enable afterward: grants for science, campaigns for healthier behavior, and broader awareness of warning signs and risk reduction.
For Southern New England, the event reinforced how local action can feed national priorities. The American Heart Association continues to position itself as a leading nonprofit focused on heart and brain health, and the Heart Ball provided both a showcase and a funding engine for that work. In a field where delays in recognition, access barriers and untreated risk factors can determine whether a patient survives an event or returns to baseline function, sustained investment in prevention and care remains central.
The region’s next challenge is familiar and unresolved: converting one night of generosity into long-term reductions in blood pressure, stroke risk, heart failure and premature death. The event raised support, but the clinical test comes later, in whether research, advocacy and access efforts can keep pace with the projected rise in cardiovascular disease.